Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000117982 | SCV000332440 | benign | not specified | 2015-07-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117982 | SCV000519885 | benign | not specified | 2016-10-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000542589 | SCV000650471 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000117982 | SCV000711696 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Gly3278Gly in exon 32 of PLEC: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 12.4% (22/178) of Japanese chromosomes from a broad population by the 1000 Genomes Project (http: //www.ncbi.nlm.nih.gov/projects/SNP; dbSNP rs61529674). |
Athena Diagnostics | RCV000117982 | SCV001475970 | benign | not specified | 2024-08-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712072 | SCV005267424 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117982 | SCV000152298 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |